AAAAAA
Results:
1-14
|
Results: 14
Authors:
Gravis, G
Mousseau, M
Douillard, JY
Dorval, T
Fabbro, M
Escudier, B
Mignot, L
Viens, P
Citation: G. Gravis et al., Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trial, EUR CYTOKIN, 12(2), 2001, pp. 239-243
Authors:
Luck, HJ
Du Bois, A
Weber, B
Pfisterer, J
Goupil, A
Kuhn, W
Barats, JC
Blohmer, J
Mousseau, M
Schroder, W
Meier, W
Mobus, V
Richter, B
Citation: Hj. Luck et al., The integration of anthracyclines in the treatment of advanced ovarian cancer, INT J GYN C, 11, 2001, pp. 34-38
Authors:
Becouarn, Y
Gamelin, E
Coudert, B
Negrier, S
Pierga, JY
Raoul, JL
Provencal, J
Rixe, O
Krisch, C
Germa, C
Bekradda, M
Mignard, D
Mousseau, M
Citation: Y. Becouarn et al., Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients, J CL ONCOL, 19(22), 2001, pp. 4195-4201
Authors:
Chauvin, C
De Oliveira, F
Ronot, X
Mousseau, M
Leverve, X
Fontaine, E
Citation: C. Chauvin et al., Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells, J BIOL CHEM, 276(44), 2001, pp. 41394-41398
Authors:
Ychou, M
Douillard, JY
Rougier, P
Adenis, A
Mousseau, M
Dufour, P
Wendling, JL
Burki, F
Mignard, D
Marty, M
Citation: M. Ychou et al., Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer - An open-label multicenterphase II study, AM J CL ONC, 23(2), 2000, pp. 143-148
Authors:
Boutonnat, J
Barbier, M
Muirhead, K
Mousseau, M
Grunwald, D
Ronot, X
Seigneurin, D
Citation: J. Boutonnat et al., Response of chemosensitive and chemoresistant leukemic cell lines to drug therapy: Simultaneous assessment of proliferation, apoptosis, and necrosis, CYTOMETRY, 42(1), 2000, pp. 50-60
Authors:
Mousseau, M
Citation: M. Mousseau, Market prosperity, democratic consolidation, and democratic peace, J CONFL RES, 44(4), 2000, pp. 472-507
Authors:
Janssens, IA
Mousseau, M
Ceulemans, R
Citation: Ia. Janssens et al., Crop ecosystem responses to climatic change: Tree crops, CLIMATE CHANGE AND GLOBAL CROP PRODUCTIVITY, 2000, pp. 245-270
Authors:
Mousseau, M
Citation: M. Mousseau, At the crossroads of plant physiology and ecology, TRENDS PL S, 4(1), 1999, pp. 1-1
Authors:
Boutonnat, J
Barbier, M
Muirhead, K
Mousseau, M
Ronot, X
Seigneurin, D
Citation: J. Boutonnat et al., Optimized fluorescent probe combinations for evaluation of proliferation and necrosis in anthracycline-treated leukaemic cell lines, CELL PROLIF, 32(4), 1999, pp. 203-213
Authors:
Mousseau, M
Shi, YH
Citation: M. Mousseau et Yh. Shi, A test for reverse causality in the democratic peace relationship, J PEACE RES, 36(6), 1999, pp. 639-663
Authors:
Viens, P
Palangie, T
Janvier, M
Fabbro, M
Roche, H
Delozier, T
Labat, JP
Linassier, C
Audhuy, B
Feuilhade, F
Costa, B
Delva, R
Cure, H
Rousseau, F
Guillot, A
Mousseau, M
Ferrero, JM
Bardou, VJ
Jacquemier, J
Pouillart, P
Citation: P. Viens et al., First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial), BR J CANC, 81(3), 1999, pp. 449-456
Authors:
Boutonnat, J
Barbier, M
Rousselle, C
Muirhead, KA
Mousseau, M
Seigneurin, D
Ronot, X
Citation: J. Boutonnat et al., Usefulness of PKHs for studying cell proliferation, CR AC S III, 321(11), 1998, pp. 901-907
Authors:
Boutonnat, J
Muirhead, KA
Barbier, M
Mousseau, M
Ronot, X
Seigneurin, D
Citation: J. Boutonnat et al., PKH26 probe in the study of the proliferation of chemoresistant leukemic sublines, ANTICANC R, 18(6A), 1998, pp. 4243-4251
Risultati:
1-14
|